Breathing News and Research

RSS

Rib movements started to facilitate locomotion, then co-opted for breathing

When early tetrapods transitioned from water to land the way they breathed air underwent an evolutionary revolution.

19 May 2020

Researchers propose a safer approach to splitting ventilators

As more Covid-19 patients experience acute respiratory distress, there has been much debate over the idea of sharing ventilators, which involves splitting air tubes into multiple branches so that two or more patients can be connected to the same machine.

19 May 2020

Gene mutation linked to MEF2C haploinsufficiency syndrome

A collaboration between scientists at the Medical University of South Carolina and clinicians at the Greenwood Genetic Center has yielded new findings about how a particular gene might regulate brain development.

19 May 2020

No SARS-COV-2 among young children in Belgium attending daycare, report researchers

A study conducted by researchers in Belgium has found no evidence to support concerns that asymptomatic young children may be a source of severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) transmission.

19 May 2020

Yoga eases depressive symptoms in people with other mental health issues

Researchers have found that the practice of yoga could help those with mental health problems by easing symptoms of depression effectively. Their study titled, "Effects of yoga on depressive symptoms in people with mental disorders: a systematic review and meta-analysis," was published in the latest issue of the British Journal of Sports Medicine. The study was funded by the National Institute for Health Research (NIHR) and Health Education England.

18 May 2020

Asthma linked to longer intubation time in younger COVID-19 patients

New data suggest that asthma is associated with longer time on ventilators for hospitalized younger patients with COVID-19.

18 May 2020

COVID-19’s adverse impact on the cardiovascular system

COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper.

15 May 2020

New technology can be used for remote monitoring of individuals with suspected COVID-19

Agência FAPESP – Developed by Biologix, a startup headquartered in São Paulo, Brazil, a sleep apnea home diagnostic and monitoring system based on the Internet of Things can be used for the remote monitoring of individuals with suspected COVID-19 or mild symptoms of the disease.

15 May 2020

Chasing the elusive dream of a COVID cure

Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.

15 May 2020

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Chimeric antigen receptor T-cell therapy, or CAR T, has become a game changer for lymphoma and leukemia patients who have relapsed or become resistant to previous treatments.

14 May 2020

Low albumin levels could predict poor outcome in COVID-19

A Spanish study has revealed that COVID-19 patients who have a low level of albumin have a poorer outcome compared to those with normal levels of blood albumin. The study titled, “Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study,” was released prior to peer-review on the open-access preprint server site Medrxiv*.

13 May 2020

Simpler ventilator design receives FDA's Emergency Use Authorization

The U.S. Food and Drug Administration has announced that the Mechanical Ventilator Milano (MVM) is safe for use in the United States under the FDA's Emergency Use Authorization, which helps support public health during the current COVID-19 pandemic.

13 May 2020

COVID-19 pandemic is taking toll on mental and physical health of smokers

The havoc wreaked by the COVID-19 pandemic is twofold: in addition to suffering direct effects of the virus, the world is grappling with the challenge of social distancing.

13 May 2020

UCF researchers win $200,000 to develop cough drops for controlling COVID-19 spread

A team of University of Central Florida researchers is looking at changing people's saliva to help manage the spread of COVID-19 as the nation gets ready to go back to work and school.

12 May 2020

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.

12 May 2020

‘No intubation’: Seniors fearful of COVID-19 are changing their living wills

Last month, Minna Buck revised a document specifying her wishes should she become critically ill.

12 May 2020

Study finds children at greater risk for severe complications from COVID-19

Children, teens and young adults are at greater risk for severe complications from COVID-19 than previously thought and those with underlying health conditions are at even greater risk, according to a study coauthored by a Rutgers researcher.

11 May 2020

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

During a May 3 appearance on "Face the Nation," Southwest CEO Gary Kelly said that he believed it was safe for Americans to fly during the coronavirus epidemic and that a plane is as safe as any other space.

11 May 2020

Study demonstrates dynamic and broad-scale immune alterations in COVID-19 patient

A new case report released on the preprint server medRxiv* provides a detailed longitudinal analysis of the immune response associated with a fatal case of coronavirus disease (COVID-19). It highlights the need for addressing the source of hyper inflammation in the treatment approach.

10 May 2020

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.

8 May 2020